213 related articles for article (PubMed ID: 27154275)
1. Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure.
Fouché M; Schäfer M; Berghausen J; Desrayaud S; Blatter M; Piéchon P; Dix I; Martin Garcia A; Roth HJ
ChemMedChem; 2016 May; 11(10):1048-59. PubMed ID: 27154275
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Studies around the Mono- and Difunctionalization of a Bioavailable Cyclic Decapeptide Scaffold.
Fouché M; Schäfer M; Blatter M; Berghausen J; Desrayaud S; Roth HJ
ChemMedChem; 2016 May; 11(10):1060-8. PubMed ID: 27094987
[TBL] [Abstract][Full Text] [Related]
3. Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides.
Nielsen DS; Lohman RJ; Hoang HN; Hill TA; Jones A; Lucke AJ; Fairlie DP
Chembiochem; 2015 Nov; 16(16):2289-93. PubMed ID: 26336864
[TBL] [Abstract][Full Text] [Related]
4. Improving on nature: making a cyclic heptapeptide orally bioavailable.
Nielsen DS; Hoang HN; Lohman RJ; Hill TA; Lucke AJ; Craik DJ; Edmonds DJ; Griffith DA; Rotter CJ; Ruggeri RB; Price DA; Liras S; Fairlie DP
Angew Chem Int Ed Engl; 2014 Nov; 53(45):12059-63. PubMed ID: 25219505
[TBL] [Abstract][Full Text] [Related]
5. Design of Thioether Cyclic Peptide Scaffolds with Passive Permeability and Oral Exposure.
Golosov AA; Flyer AN; Amin J; Babu C; Gampe C; Li J; Liu E; Nakajima K; Nettleton D; Patel TJ; Reid PC; Yang L; Monovich LG
J Med Chem; 2021 Mar; 64(5):2622-2633. PubMed ID: 33629858
[TBL] [Abstract][Full Text] [Related]
6. Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products.
Bockus AT; Lexa KW; Pye CR; Kalgutkar AS; Gardner JW; Hund KC; Hewitt WM; Schwochert JA; Glassey E; Price DA; Mathiowetz AM; Liras S; Jacobson MP; Lokey RS
J Med Chem; 2015 Jun; 58(11):4581-9. PubMed ID: 25950816
[TBL] [Abstract][Full Text] [Related]
7. Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties.
Yang Z; Zadjura LM; Marino AM; D'Arienzo CJ; Malinowski J; Gesenberg C; Lin PF; Colonno RJ; Wang T; Kadow JF; Meanwell NA; Hansel SB
J Pharm Sci; 2010 Apr; 99(4):2135-52. PubMed ID: 19780144
[TBL] [Abstract][Full Text] [Related]
8. Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides.
Witek J; Wang S; Schroeder B; Lingwood R; Dounas A; Roth HJ; Fouché M; Blatter M; Lemke O; Keller B; Riniker S
J Chem Inf Model; 2019 Jan; 59(1):294-308. PubMed ID: 30457855
[TBL] [Abstract][Full Text] [Related]
9. Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic.
Hoveyda HR; Marsault E; Gagnon R; Mathieu AP; Vézina M; Landry A; Wang Z; Benakli K; Beaubien S; Saint-Louis C; Brassard M; Pinault JF; Ouellet L; Bhat S; Ramaseshan M; Peng X; Foucher L; Beauchemin S; Bhérer P; Veber DF; Peterson ML; Fraser GL
J Med Chem; 2011 Dec; 54(24):8305-20. PubMed ID: 22106937
[TBL] [Abstract][Full Text] [Related]
10. Molecular properties that influence the oral bioavailability of drug candidates.
Veber DF; Johnson SR; Cheng HY; Smith BR; Ward KW; Kopple KD
J Med Chem; 2002 Jun; 45(12):2615-23. PubMed ID: 12036371
[TBL] [Abstract][Full Text] [Related]
11. Highly Conformationally Restricted Cyclopropane Tethers with Three-Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides.
Matsui K; Kido Y; Watari R; Kashima Y; Yoshida Y; Shuto S
Chemistry; 2017 Mar; 23(13):3034-3041. PubMed ID: 27878880
[TBL] [Abstract][Full Text] [Related]
12. Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability.
Wang CK; Northfield SE; Swedberg JE; Colless B; Chaousis S; Price DA; Liras S; Craik DJ
Eur J Med Chem; 2015 Jun; 97():202-13. PubMed ID: 25974856
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of the Absorption, Distribution, Metabolism, and Excretion of Lobeglitazone, a Novel Activator of Peroxisome Proliferator-Activated Receptor Gamma in Rats.
Lee JH; Noh CK; Yim CS; Jeong YS; Ahn SH; Lee W; Kim DD; Chung SJ
J Pharm Sci; 2015 Sep; 104(9):3049-59. PubMed ID: 25648999
[TBL] [Abstract][Full Text] [Related]
14. Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs.
Danelius E; Poongavanam V; Peintner S; Wieske LHE; Erdélyi M; Kihlberg J
Chemistry; 2020 Apr; 26(23):5231-5244. PubMed ID: 32027758
[TBL] [Abstract][Full Text] [Related]
15. Lessons for Oral Bioavailability: How Conformationally Flexible Cyclic Peptides Enter and Cross Lipid Membranes.
Linker SM; Schellhaas C; Kamenik AS; Veldhuizen MM; Waibl F; Roth HJ; Fouché M; Rodde S; Riniker S
J Med Chem; 2023 Feb; 66(4):2773-2788. PubMed ID: 36762908
[TBL] [Abstract][Full Text] [Related]
16. Improving oral bioavailability of cyclic peptides by N-methylation.
Räder AFB; Reichart F; Weinmüller M; Kessler H
Bioorg Med Chem; 2018 Jun; 26(10):2766-2773. PubMed ID: 28886995
[TBL] [Abstract][Full Text] [Related]
17. Effect of Flexibility, Lipophilicity, and the Location of Polar Residues on the Passive Membrane Permeability of a Series of Cyclic Decapeptides.
Wang S; König G; Roth HJ; Fouché M; Rodde S; Riniker S
J Med Chem; 2021 Sep; 64(17):12761-12773. PubMed ID: 34406766
[TBL] [Abstract][Full Text] [Related]
18. Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficients.
Wang CK; Northfield SE; Colless B; Chaousis S; Hamernig I; Lohman RJ; Nielsen DS; Schroeder CI; Liras S; Price DA; Fairlie DP; Craik DJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17504-9. PubMed ID: 25416591
[TBL] [Abstract][Full Text] [Related]
19. Heterocycles: Versatile control elements in bioactive macrocycles.
Soor HS; Appavoo SD; Yudin AK
Bioorg Med Chem; 2018 Jun; 26(10):2774-2779. PubMed ID: 29735427
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, oral bioavailability and metabolism of a novel isoquinolinone-based melatonin receptor agonist in rats.
Zhu J; Hu Y; Ho MK; Wong YH
Xenobiotica; 2012 Nov; 42(11):1138-50. PubMed ID: 22642804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
